• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Circ_0025033 缺失通过调节 miR-532-3p/FOXM1 网络抑制紫杉醇耐药卵巢癌细胞的紫杉醇耐药性和恶性发展。

Circ_0025033 deficiency suppresses paclitaxel resistance and malignant development of paclitaxel-resistant ovarian cancer cells by modulating the miR-532-3p/FOXM1 network.

机构信息

Department of Obstetrics and Gynecology, First Affiliated Hospital of Jinan University, Guangzhou, P. R. China.

Department of Obstetrics and Gynecology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, P. R. China.

出版信息

Immunopharmacol Immunotoxicol. 2022 Apr;44(2):275-286. doi: 10.1080/08923973.2022.2038194. Epub 2022 Feb 24.

DOI:10.1080/08923973.2022.2038194
PMID:35196944
Abstract

BACKGROUND

Ovarian cancer (OC) is the main cause of cancer-related death in women, and drug resistance is a leading cause of treatment failure. Recently, the involvement of circular RNAs (circRNAs) in cancer progression has become an area of increased investigation. The objective of this study is to uncover the function and regulatory mechanism of circ_0025033 in paclitaxel (PTX)-resistant OC cells.

METHODS

The expression of circ_0025033, FOXM1 and miR-532-3p was investigated using quantitative real-time polymerase chain reaction (qRT-PCR), and the protein expression of FOXM1 was quantified by western blot. Cell biological functions, including cell viability, migration/invasion and apoptosis, were explored using 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assays, transwell assays and flow cytometry assays. The interaction between miR-532-3p and circ_0025033 or FOXM1 predicted by bioinformatics analysis was validated by pull-down assay and dual-luciferase reporter assay. Exosomes were isolated to determine the further function of circ_0025033.

RESULT

Circ_0025033 and FOXM1 were highly expressed, while miR-532-3p was poorly expressed in OC tissues and cells, and the expression pattern was greater in PTX-resistant OC cells. Circ_0025033 knockdown lessened PTX resistance, suppressed migration/invasion and promoted apoptosis of PTX-resistant cells. With respect to mechanism, circ_0025033 upregulated the expression of FOXM1 by targeting miR-532-3p, and circ_0025033 knockdown blocked the malignant activities of PTX-resistant OC cells by enriching miR-532-3p and suppressing FOXM1. Exosomes derived from PTX-resistant cells with circ_0025033 knockdown also could repress the malignant actions of PTX-resistant OC cells.

CONCLUSION

Circ_0025033 downregulation impaired PTX resistance and malignant activities of PTX-resistant OC cells by regulating the miR-532-3p/FOXM1 network.

摘要

背景

卵巢癌(OC)是女性癌症相关死亡的主要原因,而耐药性是治疗失败的主要原因。最近,环状 RNA(circRNA)在癌症进展中的作用成为研究的热点。本研究旨在揭示 circ_0025033 在紫杉醇(PTX)耐药 OC 细胞中的功能和调控机制。

方法

采用实时定量聚合酶链反应(qRT-PCR)检测 circ_0025033、FOXM1 和 miR-532-3p 的表达,采用 Western blot 定量检测 FOXM1 的蛋白表达。采用 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐(MTT)试验、Transwell 试验和流式细胞术试验研究细胞生物学功能,包括细胞活力、迁移/侵袭和凋亡。通过下拉试验和双荧光素酶报告基因试验验证生物信息学分析预测的 miR-532-3p 与 circ_0025033 或 FOXM1 之间的相互作用。分离外泌体以确定 circ_0025033 的进一步功能。

结果

circ_0025033 和 FOXM1 在 OC 组织和细胞中高表达,而 miR-532-3p 表达水平较低,且在 PTX 耐药 OC 细胞中表达模式更为显著。circ_0025033 敲低降低了 PTX 耐药性,抑制了 PTX 耐药细胞的迁移/侵袭并促进了凋亡。就机制而言,circ_0025033 通过靶向 miR-532-3p 上调 FOXM1 的表达,而 circ_0025033 敲低通过富集 miR-532-3p 和抑制 FOXM1 阻断 PTX 耐药 OC 细胞的恶性活动。来自 circ_0025033 敲低的 PTX 耐药细胞的外泌体也可以抑制 PTX 耐药 OC 细胞的恶性作用。

结论

circ_0025033 下调通过调节 miR-532-3p/FOXM1 网络损害 PTX 耐药和 PTX 耐药 OC 细胞的恶性活动。

相似文献

1
Circ_0025033 deficiency suppresses paclitaxel resistance and malignant development of paclitaxel-resistant ovarian cancer cells by modulating the miR-532-3p/FOXM1 network.Circ_0025033 缺失通过调节 miR-532-3p/FOXM1 网络抑制紫杉醇耐药卵巢癌细胞的紫杉醇耐药性和恶性发展。
Immunopharmacol Immunotoxicol. 2022 Apr;44(2):275-286. doi: 10.1080/08923973.2022.2038194. Epub 2022 Feb 24.
2
Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through the regulation of ZEB1 expression by sponging miR-124-3p.环状 RNA circ-PVT1 通过海绵吸附 miR-124-3p 调控 ZEB1 表达促进胃癌细胞对紫杉醇耐药。
Biosci Rep. 2019 Dec 20;39(12). doi: 10.1042/BSR20193045.
3
Circ_0011292 knockdown mitigates progression and drug resistance in PTX-resistant non-small-cell lung cancer cells by regulating miR-433-3p/CHEK1 axis.环状 RNA 0011292 通过调控 miR-433-3p/CHEK1 轴抑制紫杉醇耐药非小细胞肺癌的进展和耐药性。
Thorac Cancer. 2022 May;13(9):1276-1288. doi: 10.1111/1759-7714.14378. Epub 2022 Mar 29.
4
Circ-FOXM1 contributes to cell proliferation, invasion, and glycolysis and represses apoptosis in melanoma by regulating miR-143-3p/FLOT2 axis.环状 RNA-FOXM1 通过调控 miR-143-3p/FLOT2 轴促进黑色素瘤细胞增殖、侵袭和糖酵解并抑制细胞凋亡。
World J Surg Oncol. 2020 Mar 17;18(1):56. doi: 10.1186/s12957-020-01832-9.
5
Circ_0061140 knockdown inhibits tumorigenesis and improves PTX sensitivity by regulating miR-136/CBX2 axis in ovarian cancer.Circ_0061140 敲低通过调节 miR-136/CBX2 轴抑制卵巢癌细胞的肿瘤发生并提高 PTX 敏感性。
J Ovarian Res. 2021 Oct 14;14(1):136. doi: 10.1186/s13048-021-00888-9.
6
Circ_0,007,331 Promotes the PTX Resistance and Progression of Breast Cancer via miR-200b-3p/ANLN.环状 RNA 0,007,331 通过 miR-200b-3p/ANLN 促进乳腺癌的 PTX 耐药和进展。
J Surg Res. 2022 Nov;279:619-632. doi: 10.1016/j.jss.2022.05.004. Epub 2022 Aug 1.
7
Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.环状 RNA-RNF111 通过 miR-140-5p 升高 E2F3 表达促进乳腺癌对紫杉醇耐药。
Thorac Cancer. 2020 Jul;11(7):1891-1903. doi: 10.1111/1759-7714.13475. Epub 2020 May 23.
8
CircATL2 enhances paclitaxel resistance of ovarian cancer via impacting miR-506-3p/NFIB axis.环状RNA ATL2通过影响miR-506-3p/NFIB轴增强卵巢癌对紫杉醇的耐药性。
Drug Dev Res. 2022 Apr;83(2):512-524. doi: 10.1002/ddr.21882. Epub 2021 Sep 19.
9
CircEXOC6B Suppresses the Proliferation and Motility and Sensitizes Ovarian Cancer Cells to Paclitaxel Through miR-376c-3p/FOXO3 Axis.环状 RNA EXOC6B 通过 miR-376c-3p/FOXO3 轴抑制卵巢癌细胞增殖、迁移并增加其对紫杉醇的敏感性。
Cancer Biother Radiopharm. 2022 Nov;37(9):802-814. doi: 10.1089/cbr.2020.3739. Epub 2020 Oct 2.
10
Long non-coding RNA UCA1 promotes the progression of paclitaxel resistance in ovarian cancer by regulating the miR-654-5p/SIK2 axis.长链非编码 RNA UCA1 通过调控 miR-654-5p/SIK2 轴促进卵巢癌对紫杉醇耐药。
Eur Rev Med Pharmacol Sci. 2020 Jan;24(2):591-603. doi: 10.26355/eurrev_202001_20035.

引用本文的文献

1
Circular RNAs: key regulators of paclitaxel sensitivity and resistance in cancer.环状RNA:癌症中紫杉醇敏感性和耐药性的关键调节因子
Eur J Med Res. 2025 Aug 18;30(1):758. doi: 10.1186/s40001-025-03045-w.
2
Exosomes in ovarian cancer: Impact on drug resistance and advances in SERS detection techniques.卵巢癌中的外泌体:对耐药性的影响及表面增强拉曼散射检测技术的进展
J Pharm Anal. 2025 Jul;15(7):101170. doi: 10.1016/j.jpha.2024.101170. Epub 2024 Dec 18.
3
Progress of targeted FOX family therapy in ovarian cancer.卵巢癌中靶向FOX家族治疗的进展
Front Pharmacol. 2025 Jul 17;16:1604998. doi: 10.3389/fphar.2025.1604998. eCollection 2025.
4
Research progress on FOXM1 in ovarian cancer diagnosis and therapeutics.FOXM1在卵巢癌诊断与治疗中的研究进展
Front Oncol. 2025 Jun 19;15:1598868. doi: 10.3389/fonc.2025.1598868. eCollection 2025.
5
Emerging roles of exosomes in diagnosis, prognosis, and therapeutic potential in ovarian cancer: a comprehensive review.外泌体在卵巢癌诊断、预后及治疗潜力中的新兴作用:综述
Cancer Gene Ther. 2025 Feb;32(2):149-164. doi: 10.1038/s41417-025-00871-2. Epub 2025 Jan 22.
6
Screening and molecular mechanism research on bile microRNAs associated with chemotherapy efficacy in perihilar cholangiocarcinoma.肝门部胆管癌化疗疗效相关胆汁微小RNA的筛选及分子机制研究
iScience. 2024 Dec 4;27(12):111437. doi: 10.1016/j.isci.2024.111437. eCollection 2024 Dec 20.
7
Interplay of microRNAs and circRNAs in Epithelial Ovarian Cancer.微小RNA与环状RNA在上皮性卵巢癌中的相互作用
Noncoding RNA. 2024 Sep 30;10(5):51. doi: 10.3390/ncrna10050051.
8
Exosomal noncoding RNAs in gynecological cancers: implications for therapy resistance and biomarkers.妇科癌症中的外泌体非编码RNA:对治疗耐药性和生物标志物的影响
Front Oncol. 2024 Apr 26;14:1349474. doi: 10.3389/fonc.2024.1349474. eCollection 2024.
9
Role of circular RNA as competing endogenous RNA in ovarian cancer (Review).环状 RNA 作为卵巢癌竞争内源性 RNA 的作用(综述)。
Int J Mol Med. 2024 May;53(5). doi: 10.3892/ijmm.2024.5365. Epub 2024 Mar 8.
10
The role of circRNAs in regulation of drug resistance in ovarian cancer.环状RNA在卵巢癌耐药调控中的作用
Front Genet. 2023 Dec 13;14:1320185. doi: 10.3389/fgene.2023.1320185. eCollection 2023.